For instance, studies in ALS mouse models have demonstrated that rTMS can induce transcription of glial fibrillary acidic protein (GFAP), a marker of astrocyte activation that is dysregulated in ALS and other neurodegenerative diseases [64]. This evidence concerns the gene GFAP and neurodegenerative disease.